Tejal Vishalpura

Tejal Vishalpura is a highly accomplished pharmaceutical industry executive with extensive experience in marketing, strategy, and leadership roles. She currently serves as the Senior Vice President of Commercial Strategy & Marketing at Novo Nordisk, a position she has held since January 2024.12

Prior to joining Novo Nordisk, Tejal held several key positions at Novartis, including:

1. VP, Global Head of Capabilities Excellence and Learning (October 2022 - March 2023)
2. VP, Global Head of Marketing and Launch Excellence (August 2021 - September 2022)
3. VP, US Head of Immunology, Inflammatory Diseases, and Transplant Business Unit (September 2019 - August 2021)
4. VP, US Market Access National Payers and PBMs (July 2018 - September 2019)3

Before her tenure at Novartis, Tejal worked at GlaxoSmithKline (GSK) in various leadership roles, including VP of Pipeline and Early Medicines Development, VP of US Primary Care Sales, and Global Head of Digital Transformation.3

Tejal holds a Doctor of Pharmacy (PharmD) degree from The Ohio State University and has received executive education from The Wharton School.31 She is known for her expertise in commercial strategy, marketing excellence, and her passion for advancing employee capabilities to support the development of innovative medicines.1